Basic Information
Briviact
50474-870
Regulatory Information
50474-870
NDA205838
C73594
May 24, 2023
USA
These highlights do not include all the information needed to use BRIVIACT safely and effectively. See full prescribing information for BRIVIACT. BRIVIACT (brivaracetam) tablets, for oral use, CV BRIVIACT (brivaracetam) oral solution, CV BRIVIACT (brivaracetam) injection, for intravenous use, CV Initial U.S. Approval: 2016
HUMAN PRESCRIPTION DRUG LABEL
19
Company Information
028526403
Active Ingredients
anhydrous citric acid
Code: XF417D3PSL
Class Code: IACT
sodium citrate, unspecified form
Code: 1Q73Q2JULR
Class Code: IACT
methylparaben
Code: A2I8C7HI9T
Class Code: IACT
carboxymethylcellulose sodium, unspecified
Code: K679OBS311
Class Code: IACT
sucralose
Code: 96K6UQ3ZD4
Class Code: IACT
water
Code: 059QF0KO0R
Class Code: IACT
sorbitol
Code: 506T60A25R
Class Code: IACT
glycerin
Code: PDC6A3C0OX
Class Code: IACT
Active Moieties
brivaracetam
Code: U863JGG2IA